170 related articles for article (PubMed ID: 23642315)
1. Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting.
Werb D; Kerr T; Buxton J; Shoveller J; Richardson C; Montaner J; Wood E
Drug Alcohol Depend; 2013 Oct; 132(3):535-40. PubMed ID: 23642315
[TBL] [Abstract][Full Text] [Related]
2. Increasing awareness about HIV prevention among young people who initiated injection drug use in a Canadian setting, 1988-2014.
Bahji A; Wood E; Ahamad K; Dong H; DeBeck K; Milloy MJ; Kerr T; Hayashi K
Int J Drug Policy; 2015 Dec; 26(12):1258-64. PubMed ID: 26514080
[TBL] [Abstract][Full Text] [Related]
3. An external evaluation of a peer-run outreach-based syringe exchange in Vancouver, Canada.
Hayashi K; Wood E; Wiebe L; Qi J; Kerr T
Int J Drug Policy; 2010 Sep; 21(5):418-21. PubMed ID: 20359877
[TBL] [Abstract][Full Text] [Related]
4. Ability to access community-based needle-syringe programs and injecting behaviors among drug users: a cross-sectional study in Hunan Province, China.
Zhang L; Chen X; Zheng J; Zhao J; Jing J; Zhang J; Chow EP; Wilson DP
Harm Reduct J; 2013 May; 10():8. PubMed ID: 23651665
[TBL] [Abstract][Full Text] [Related]
5. Needle and syringe distribution trends in Western Australia, 1990 to 2009.
Lilley G; Mak DB; Fredericks T
Drug Alcohol Rev; 2013 May; 32(3):320-7. PubMed ID: 22963615
[TBL] [Abstract][Full Text] [Related]
6. Recent incarceration independently associated with syringe sharing by injection drug users.
Wood E; Li K; Small W; Montaner JS; Schechter MT; Kerr T
Public Health Rep; 2005; 120(2):150-6. PubMed ID: 15842116
[TBL] [Abstract][Full Text] [Related]
7. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
8. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
Wilson H; Brener L; Mao L; Treloar C
Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
[TBL] [Abstract][Full Text] [Related]
9. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
[TBL] [Abstract][Full Text] [Related]
10. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis.
Sawangjit R; Khan TM; Chaiyakunapruk N
Addiction; 2017 Feb; 112(2):236-247. PubMed ID: 27566970
[TBL] [Abstract][Full Text] [Related]
12. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?
Wood E; Tyndall MW; Spittal PM; Li K; Kerr T; Hogg RS; Montaner JS; O'Shaughnessy MV; Schechter MT
CMAJ; 2001 Aug; 165(4):405-10. PubMed ID: 11531048
[TBL] [Abstract][Full Text] [Related]
13. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
[TBL] [Abstract][Full Text] [Related]
14. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention.
Wood E; Spittal PM; Kerr T; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
Can J Public Health; 2003; 94(5):355-9. PubMed ID: 14577743
[TBL] [Abstract][Full Text] [Related]
15. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
O'Keefe D; Aitken C; Scott N; Dietze P
Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
[TBL] [Abstract][Full Text] [Related]
16. Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15.
Glass R; Hope VD; Njoroge J; Edmundson C; Smith J; McVeigh J; Parry J; Desai M
Drug Alcohol Depend; 2019 Feb; 195():40-44. PubMed ID: 30580202
[TBL] [Abstract][Full Text] [Related]
17. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
Iversen J; Topp L; Wand H; Maher L
Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia.
O'Keefe D; Scott N; Aitken C; Dietze P
Drug Alcohol Depend; 2017 Jul; 176():7-13. PubMed ID: 28463684
[TBL] [Abstract][Full Text] [Related]
19. An examination of injection drug use trends in Victoria and Vancouver, BC after the closure of Victoria's only fixed-site needle and syringe programme.
Ivsins A; Chow C; Macdonald S; Stockwell T; Vallance K; Marsh DC; Michelow W; Duff C
Int J Drug Policy; 2012 Jul; 23(4):338-40. PubMed ID: 22280916
[TBL] [Abstract][Full Text] [Related]
20. A qualitative assessment of injection drug use and harm reduction programmes in Kabul, Afghanistan: 2006-2007.
Todd CS; Stibich MA; Stanekzai MR; Rasuli MZ; Bayan S; Wardak SR; Strathdee SA
Int J Drug Policy; 2009 Mar; 20(2):111-20. PubMed ID: 18207381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
